|
|
|
LifeScienceHistory.com - Check us out on Instagram
New Jersey Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New JerseyLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Catalent, Inc.
| | | Phone: | (732) 537-6325 | Fax: | (732) 537-5932 | Year Established: | 2007 | Ticker: | CTLT | Exchange: | NYSE | Main Contact: | John Chiminski, CEO | | Other Contacts: | Jonathan Arnold, President, Oral Drug Delivery Paul Hegwood, Jr., President, Clinical Supply Services Steven Fasman, Senior VP & General Counsel Will Downie, Senior VP, Global Sales & Marketing Barry Littlejohns, President, Drug Delivery Solutions Aris Gennadios, President, Softgel Technologies Wetteny Joseph, Senior VP & CFO Alessandro Maselli, Senior VP, Global Operations Scott Gunther, Senior VP, Quality & Regulatory Affairs
| | Company Description | Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 10,000 people, including over 1,400 scientists, at more than 30 facilities across five continents. | |
|
|
|
|
|